Premium Roundup Lawsuit Lead Generation & Signed Retainer Services
In 2026, law firms know that it is easy to find people who used weedkillers, but it is much harder to find claimants who meet the strict rules of the settlement point system.
At Exclusive Leads Agency (ELA), we provide roundup lawsuit lead generation built for these high standards. We identify people with a confirmed diagnosis of Non-Hodgkin Lymphoma (NHL) and the specific brand-name usage history required for a claim. Every lead is exclusive to your firm and comes with the documents your intake team needs to move forward without delay.
Get Qualified Leads Sent to You
Specialized Roundup Mass Tort Lead Generation Services
Roundup is one of the biggest environmental lawsuits in U.S. history. Although billions have already been paid out, new cases of illness continue to occur. This is because Non-Hodgkin Lymphoma (NHL) can take years to show up after someone uses the product. As a result, new and qualified claimants keep coming.
Round-up mass tort case leads require more scrutiny than standard injury cases. However, the current market for these leads is often full of low-quality data and shared info that wastes your time.
Therefore, we look for these specific factors: the exact exposure hours, how long they used the product, and the medical details that Bayer’s settlement rules require. Once we have the brand name and the timing of the illness, we help you build a solid list of cases ready for recovery.
Roundup Case Qualification Criteria
We use strict standards to ensure every roundup injury lawsuit lead we offer is genuine and has a valid claim.
Qualifying Cancer Diagnoses
Non-Hodgkin Lymphoma is the main injury we look for in these cases. We screen for:
- Main Subtypes: Diffuse Large B-Cell Lymphoma (DLBCL), Chronic Lymphocytic Leukemia (CLL), and Follicular Lymphoma.
- Other Accepted Subtypes: Small Lymphocytic Lymphoma (SLL), Mantle Cell Lymphoma, and Hairy Cell Leukemia.
- Medical Timing: We look for diagnoses that occurred after a clear period of exposure, typically from the year 2000 to the present.
Exposure Requirements
We check every roundup lead to ensure the claimant used the product enough to meet the requirements for a successful filing. Our screening includes:
- Exposure Intensity: At least 10 hours across a person’s lifetime and 10 different uses.
- Duration of Use: At least two years of regular use of the product.
- Exposure Context: We determine whether the exposure was residential, business (e.g., landscaping or maintaining a golf course), or agricultural. Agricultural and occupational exposures are highly valued because they usually involve more direct contact with the chemical.
Timeline and Latency Requirements
The timing of the first use and the date of diagnosis must align with established scientific and legal latency standards.
- The Latency Gap: We require at least one year between the first exposure and the NHL diagnosis.
- Usage Dates: We focus on cases where the user was exposed to Roundup before 2015. This is a key date because the World Health Organization labeled glyphosate as a “probable carcinogen” that year.
- Age at Diagnosis: The claimant must be 18-80 years old at the time of diagnosis.
Documentation Requirements
An ELA roundup lead package includes the proof needed to move a case toward a settlement:
- Lab Results: Biopsy findings that confirm the specific type of NHL.
- Medical Records: History of chemotherapy, radiation, or other treatments.
- Proof of Use: Old receipts, photos of the jugs, or work records for professional sprayers.
Our 5-Step C.L.A.I.M. Validation Process for Roundup Leads
We process every potential claimant through a system designed to protect your firm’s intake efficiency.
C – Claimant Identity Verification
We check the person’s ID and their previous addresses. This confirms they were actually in the right areas when using Roundup.
L – Legal & Compliance Screening
Every roundup legal leads delivery includes a TrustedForm certificate. This provides a clear record of consent and ensures that your firm complies with all TCPA and HIPAA regulations.
A – Approved Diagnosis Documentation
We request the lab reports and medical records that support the diagnosis. Knowing the exact cancer stage and subtype before you sign the case saves your team hours of work.
I – Injury Validation Cross-Check
Our specialists conduct detailed interviews to document the illness’s history. We record when symptoms first appeared, the types of scans used for diagnosis, and the claimant’s current health status.
M – Mass Tort Exposure Evidence
We collect information about how and when Roundup was used to build a strong case.
- Application Method: We confirm how the product was applied, such as by hand sprayer, tractor-mounted boom, or industrial equipment.
- Frequency and Timing: We record the product’s usage frequency and seasons to demonstrate a distinct exposure pattern.
- Brand Verification: We verify that the user used the brand-name Roundup. This is a critical requirement for liability in most court cases.
Why Law Firms Choose ELA for Roundup Leads
The Roundup market is tricky, and many vendors just don’t have the right experience. We are the best option for most companies because we know how to find the most valuable cases.
- Settlement Tier Knowledge: We know exactly how the point system works. We look for cases that receive more points, such as those who used the product for work or have a more severe form of cancer.
- Strict Exclusivity: We never broker or share leads. Once you receive a lead, it is yours alone.
- Real-Time Delivery: Speed is critical in mass torts. We deliver leads as soon as they are qualified.
- Performance Focus: We measure our success by the number of cases you actually file, not by the number of forms you fill out.
Attorney-Approved Expertise in Roundup Mass Tort Litigation
Roundup cases are different from other lawsuits. Our process is built on years of tracking Mass Tort Multi-District Litigation (MDL). We target the specific factors that drive case value:
- Settlement Points: We screen for details that earn more points, such as the claimant’s age at diagnosis and the specific cancer subtype.
- Work-Related Exposure: We prioritize high-value cases involving farmers, landscapers, and groundskeepers who used the product professionally.
- Usage Evidence: We look for the receipts, work records, or photos needed to prove that brand-name Roundup was used.
- High-Intensity Screening: Our process identifies users who frequently handle the chemical for extended periods, a key factor in a successful toxic tort claim.
Our Roundup Lead Generation & Delivery Process
If you want to find qualified Roundup claimants in 2026, you will need deep-dive medical screening.
Targeted Marketing
To find the right people, we run ad campaigns targeting long-term Roundup users. We focus our marketing on farming communities and areas with many professional landscaping and lawn care businesses.
Complete Case Profiles
Every lead we deliver includes:
- Detailed Exposure Data: Duration, frequency, and type of application.
- Medical Summaries: Diagnosis date, NHL subtype, and treatment history.
- Documentation Status: An assessment of available records.
- Verified Contact Info: Accurate phone numbers and emails with preferred contact times.
Premium Signed Retainer Services
We offer a full service for firms that want to receive cases already signed and ready for litigation. Our intake specialists are skilled at managing the sensitivity of cancer claims and ensuring that all necessary legal paperwork, such as HIPAA authorizations and representation agreements, is properly completed. This service allows you to scale your practice without adding overhead to your internal intake department.
Understanding Roundup Litigation: Background and Science
The legal arguments against glyphosate are based on decades of development and corporate oversight.
Litigation Background
Monsanto first sold Roundup in 1974. For years, it was marketed as safe. Everything changed in 2015 when the WHO labeled its main ingredient a carcinogen.
- 1974-1996: Major trials, like the Johnson and Pilliod cases, resulted in massive awards. These wins proved that Roundup causes cancer and that the company failed to warn people.
- Bayer Acquisition: In 2018, Bayer acquired Monsanto and assumed all its legal liabilities. Since then, they have spent billions of dollars on settlements.
- The $11 Billion Fund: Bayer set up a massive fund to pay claims, but thousands of cases remain active.
- 2026 Update: As of 2026, Bayer has proposed a new multi-billion-dollar settlement to handle current and future claims.
- Ongoing Risks: The product’s continued use on farms and in backyards results in new diagnoses and lawsuits each year.
Scientific Evidence Linking Roundup to NHL
Research from the University of Washington shows a clear link between heavy Roundup use and a higher risk of cancer. While some government agencies still debate these findings, the courts have already moved forward. As a result, victims now have a clear legal route to receive compensation.
Landmark Verdicts and Settlement Structure
Most Roundup settlements are distributed through a point system. Higher points and therefore higher compensation are typically awarded based on:
- The severity and subtype of the NHL.
- The intensity of the exposure (occupational vs. occasional).
- The claimant’s age at the time of diagnosis.
- The length of the latency period.
Current Roundup Litigation Status
The current status of Roundup litigation offers a unique advantage: the compensation rules are already clear. ELA’s verified leads help your firm build a docket of high-tier cases with predictable settlement values.
Settlement Value Potential for Roundup Cases
A point-based system determines case value. Therefore, each file is reviewed against specific tiers to decide the payout amount, such as
|
Tier |
Value Level |
Primary Criteria |
|
Tier 1 |
Highest |
Tier 1 is characterized by young age, an aggressive NHL subtype, and long-term professional exposure. |
|
Tier 2 |
High |
There is clear medical evidence and a significant exposure history. |
|
Tier 3 |
Moderate |
Basic requirements met; shorter exposure or older age at diagnosis. |
|
Tier 4 |
Minimum |
The diagnosis must be qualified with minimal “enhancement points.” |
Factors That Increase Case Value
- Cancer Type
- Exposure Level.
- Age at Diagnosis
- Usage Type
- Timing.
- Treatment
Note: These tiers are based on current settlement frameworks and do not guarantee payment.
The Litigation Opportunity for Law Firms
- Available Funding: A multi-billion-dollar settlement fund is currently available to resolve current and future claims. This provides a clear path to compensation without the uncertainty of a trial.
- New Claimants: Because Roundup is still sold and used on farms and in yards today, new people are being diagnosed every year.
- Latency Pipeline: NHL often takes 10 to 15 years to develop after exposure. This creates a long-term stream of qualified claimants who are only now becoming eligible to file.
- Structured Payouts: The “point system” reduces risk for law firms. You can now estimate a case’s value early in the process using proven criteria.
- Efficient Processing: With the MDL (Multi-District Litigation) framework, cases move through the system much faster than they did during the early years of the litigation.
- Lower Competition: Many firms moved on after the first major settlements. This means it is now more affordable to find and sign high-quality leads.
Contact Us for Roundup Lead Availability
We have state-specific availability and can tailor our screening to your firm’s criteria. Reach out today to discuss your goals and review our pricing options.
Frequently Asked Questions
These are pre-screened individuals who used brand-name Roundup and have a confirmed diagnosis of Non-Hodgkin Lymphoma.
Non-Hodgkin Lymphoma (NHL) is the main qualifying diagnosis. This includes subtypes like DLBCL, CLL, and Mantle Cell Lymphoma.
Most firms require at least 10 hours of use and 10 separate applications over at least two years.
New cases are still being filed as the latency period for NHL means people are still being diagnosed years after their exposure.
We conduct detailed interviews to confirm the product used was brand-name Roundup rather than a generic glyphosate product.
Every lead we provide is 100% exclusive to your firm.
It is a method of calculating compensation based on the severity of the illness, the amount of exposure, and the claimant's age.
We offer a Premium Signed Retainer service that handles the entire intake and signing process for you.
